The US House Appropriations Committee on 4 June approved a 2020 budget bill for the Food and Drug Administration asking the agency to brief Congress on approvals of non-pharmacological pain relievers, investigate the use of corneal crosslinking devices and complete breast density reporting rules.
Congress also wants the FDA to address the shortage of immediate-release (IR) naloxone delivery devices for heroin overdoses, incentivize development of opioid-abuse deterrents and addiction treatments, and “ensure epinephrine auto...